in a one-year , double-masked , randomized study , the ocular hypotensive efficacy of twice-daily treatment with 0.25 % levobunolol hydrochloride or timolol maleate was evaluated in 78 patients with glaucoma or ocular hypertension ( phase 1 ) .
C0017601
glaucoma
C0028840
ocular hypertension